Cargando…
Which vaccination strategy against COVID-19?
BACKGROUND: Bottlenecks in the production and supply pipeline of vaccines against coronavirus disease 2019 have led some countries to consider the option of dose-sparing strategies (e.g., increasing the number of people who receive some vaccine by halving the dose or increasing the interval between...
Autores principales: | De Matteis, Alessandro, Turkmen Ceylan, Fethiye B, Urpis, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213840/ https://www.ncbi.nlm.nih.gov/pubmed/35640006 http://dx.doi.org/10.1093/inthealth/ihac023 |
Ejemplares similares
-
Vaccine or monoclonal therapy: which is the winning weapon against COVID-19?
por: Lo Muzio, Lorenzo, et al.
Publicado: (2021) -
Therapeutic strategies to fight COVID‐19: Which is the status artis?
por: Scavone, Cristina, et al.
Publicado: (2021) -
The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-19
por: Borralleras, Cristina, et al.
Publicado: (2023) -
Serum Visfatin and Fetuin-A Levels and Glycemic Control in Patients with Obese Type 2 Diabetes Mellitus
por: Gunduz, Fethiye Oztop, et al.
Publicado: (2011) -
Vaccination strategies against COVID-19 and the diffusion of anti-vaccination views
por: Prieto Curiel, Rafael, et al.
Publicado: (2021)